Oncology

TNG908 Phase 2 Results Expected

TNG908 • Locally Advanced Solid Tumor

LP-300 Phase 2 Results Expected

LP-300 • Adenocarcinoma of Lung

BNT142 Phase 2 Results Expected

BNT142 • Solid Tumor

Selinexor (combination therapy) Phase 3 Results Expected

Selinexor (combination therapy) • Relapsed/Refractory Diffuse Large B-cell Lymphoma

Aglatimagene besadenovec Phase 2 Results Expected

aglatimagene besadenovec • Prostate Cancer

SAR444200 Phase 2 Results Expected

SAR444200 • Neoplasm

pembrolizumab (KEYTRUDA®) Phase 2 Results Expected

pembrolizumab (KEYTRUDA®) • Melanoma Metastatic

TNG260 Phase 2 Results Expected

TNG260 • Non Small Cell Lung Cancer

Narazaciclib Phase 2 Results Expected

Narazaciclib • Endometrioid Endometrial Cancer

MRTX849 Phase 3 Results Expected

MRTX849 • Advanced Cancer